USPTO serial 99847188
R3 STEM CELL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- RIOS, SASHA BOSHART
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with R3 STEM CELL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Marc Cullen Goldsen
Marc Cullen Goldsen Davis Miles, PLLC999 East Playa Del Norte Drive, Suite 510Tempe, AZ 85288United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business management assistance; Business management consultancy; Consultancy regarding advertising communication strategies; Consultancy regarding public relations communication strategies; Dissemination of advertising matter; Distribution of prospectuses and samples; Market intelligence services; Sales promotion for others; Professional business consultancy; Business management consulting, strategic planning and business advisory services provided to connect regenerative medicine treatment providers with patients and clients and to connect patients and clients with regenerative medicine treatment providers | ACTIVE | Mar 1, 2014 |
| 042 | Medical and scientific research in the field of regenerative medicine; Medical and scientific research, namely, conducting clinical trials for others; Biological research and analysis; Stem cell research services; Scientific laboratory services | ACTIVE | Mar 1, 2014 |
| 044 | Health care; Medical analysis for the diagnosis and treatment of persons; Medical diagnosis and treatment of Achilles tears, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, ankle sprains, arthritis, autism, autoimmune diseases, namely, rheumatoid arthritis (RA), lupus and psoriasis, back pain, cardiomyopathy, carpal tunnel syndrome, cartilage defects, chronic obstructive pulmonary disease (COPD), Complex Regional Pain Syndrome (CRPS), degenerative disc disease, diabetes, erectile dysfunction (ED), facet syndrome, failed back surgery syndrome (FBSS), fractures, headaches and heart failure; Medical diagnosis and treatment of interstitial cystitis, kidney failure, knee ligament injuries, lichen sclerosus, Lyme disease, migraines, multiple sclerosis (MS), neck pain, neuropathy, Parkinson's disease, pelvic pain, phantom limb pain, plantar fasciitis, postherpetic neuralgia, post-laminectomy syndrome, pudendal neuralgia, reflex sympathetic dystrophy (RSD), rotator cuff tears, sacroiliac (SI) joint pain, sciatica, spinal stenosis, stroke, tendonitis, tension headaches and trigeminal neuralgia; Health center services; Health clinic services; Regenerative medicine services; Stem cell therapy services | ACTIVE | Mar 1, 2014 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Greene Technologies, LLC
- Other trademarks owned by Greene Technologies, LLC
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named R3 STEM CELL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 27, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 21, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 29, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 28, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 28, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 28, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 27, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 25, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 24, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 26, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 26, 2026 | NWAP | NEW APPLICATION ENTERED | — |